Beleaguered Avinger, is slashing more jobs. Source: BioSpace

Novartis is not resting on the laurels of having the first-ever-approval for a CAR-T cancer drug, Kymriah. Source: BioSpace

Albert Bourla, 56, has been the Group President of Pfizer’s Innovative Health Business since the beginning of 2016. Source: BioSpace

After falling short of analysts' expectations in its latest quarter, Novo Nordisk is restructuring its commercial operations as it looks to fend off challenges to its products. Source: BioSpace

The initial results were presented at the 2017 Society for Immunotherapy of Cancer (SITC) Annual Meeting. Source: BioSpace

Now totaling $227M, Arcus Biosciences announced it had closed a $107M Series C financing. Source: BioSpace

Neurotoxicity killed JCAR015 right along with 5 patients in the lead pivotal study, derailing Juno Therapeutics. Source: BioSpace

Investors in beleaguered Argos are smiling this morning after the company announced some positive interim data for its Phase III kidney cancer drug, Rocapuldencel-T - a trial that some said…

During the presidential campaign of 2015-2016, one of the areas that got some of the largest scrutiny was drug pricing, and with good reason. Source: BioSpace

There's nothing like a billion-plus dollar deal to make investors happy on a Monday. Source: BioSpace